摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

trimethyl-3H-oxazol-2-one | 98196-74-8

中文名称
——
中文别名
——
英文名称
trimethyl-3H-oxazol-2-one
英文别名
Trimethyl-3H-oxazol-2-on;3,4,5-Trimethyl-1,3-oxazol-2-one
trimethyl-3<i>H</i>-oxazol-2-one化学式
CAS
98196-74-8
化学式
C6H9NO2
mdl
——
分子量
127.143
InChiKey
RPAASNWVRKKJHA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.7
  • 重原子数:
    9
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    29.5
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS
    申请人:INTERMUNE, INC.
    公开号:US20140200215A1
    公开(公告)日:2014-07-17
    Compounds, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds to treat, prevent or diagnose diseases, disorders, or conditions associated with one or more of the lysophosphatidic acid receptors are provided.
    提供的是化合物、制造这些化合物的方法、包含这些化合物的药物组合物和药品,以及使用这些化合物来治疗、预防或诊断与一个或多个溶血磷脂酸受体相关的疾病、失调或状况的方法。
  • [EN] NOVEL COMPOUNDS, USES AND METHODS FOR THEIR PREPARATION<br/>[FR] NOUVEAUX COMPOSÉS, LEURS UTILISATIONS ET PROCÉDÉS DE PRÉPARATION
    申请人:FRONTHERA U S PHARMACEUTICALS LLC
    公开号:WO2018031680A1
    公开(公告)日:2018-02-15
    The present disclosure relates to novel compounds HIF-2α inhibitors and pharmaceutical compositions thereof which may be useful in the treatment and/or prevention of various conditions. The present disclosure also provides methods of preparing such HIF-2α inhibitors and compositions, and methods of using the same.
    本发明涉及新颖的HIF-2α抑制剂化合物及其药物组合物,这些化合物可能对治疗和/或预防各种病症有用。本发明还提供了制备此类HIF-2α抑制剂及其组合物的方法,以及使用这些抑制剂和组合物的方法。
  • ANTIVIRAL COMPOUNDS
    申请人:Aktoudianakis Evangelos
    公开号:US20100022508A1
    公开(公告)日:2010-01-28
    The invention is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.
    这项发明涉及抗病毒化合物,含有这种化合物的组合物,以及包括给予这种化合物的治疗方法,还涉及用于制备这种化合物的过程和中间体。
  • CHROMENE COMPOUND
    申请人:Takahashi Toshiaki
    公开号:US20120270071A1
    公开(公告)日:2012-10-25
    A chromene compound having a skeleton represented by the following formula (1) and exhibiting double peak characteristic: wherein Z is a group represented by any one of the following formulas: n is an integer of 1 to 3, when n is 2 or 3, Z′ s may be the same or different, with the proviso that when n is 1, Z cannot be —CH 2 —, and when n is 2 or 3, Z's cannot be —CH 2 — at the same time; R 1 is an electron absorbing group having a Hammett constant σ p of more than 0, with the proviso that when there are a plurality of R 1 's, R 1 's may be the same or different; and X and Y are each independently an oxygen atom or ═NR 2 , with the proviso that X and Y cannot be oxygen atoms at the same time.
  • STEREO IMAGE PRINT AND METHOD OF PRODUCING THE SAME
    申请人:FUJIFILM CORPORATION
    公开号:US20130120676A1
    公开(公告)日:2013-05-16
    Provided is a stereo image print observable without polarized glasses, having a transparent support; first and second laminate disposed on a surface, respectively, of the transparent support, each laminate having an image layer satisfying condition (1) and a protective layer having at least one layer satisfying condition (2), the image layer and the protective layer being disposed in this order from the transparent support side: (1) each image layer has a dichroic image including pixels for a left eye and pixels for a right eye arranged in a predetermined array, each pixel having at least one kind of horizontally aligned dichroic dye, and absorption axes of the dichroic images in the first and the second laminates are orthogonal to each other, (2) the protective layer has an in-plane retardation value (Re) 10 mm or less for visible light.
查看更多

同类化合物

伊莫拉明 (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5-氨基-1,3,4-噻二唑-2-基)甲醇 齐墩果-2,12-二烯[2,3-d]异恶唑-28-酸 黄曲霉毒素H1 高效液相卡套柱 非昔硝唑 非布索坦杂质Z19 非布索坦杂质T 非布索坦杂质K 非布索坦杂质E 非布索坦杂质67 非布索坦杂质65 非布索坦杂质64 非布索坦杂质61 非布索坦代谢物67M-4 非布索坦代谢物67M-2 非布索坦代谢物 67M-1 非布索坦-D9 非布索坦 非唑拉明 雷西纳德杂质H 雷西纳德 阿西司特 阿莫奈韦 阿米苯唑 阿米特罗13C2,15N2 阿瑞匹坦杂质 阿格列扎 阿扎司特 阿尔吡登 阿塔鲁伦中间体 阿培利司N-1 阿哌沙班杂质26 阿哌沙班杂质15 阿可替尼 阿作莫兰 阿佐塞米 镁(2+)(Z)-4'-羟基-3'-甲氧基肉桂酸酯 锌1,2-二甲基咪唑二氯化物 铵2-(4-氯苯基)苯并恶唑-5-丙酸盐 铬酸钠[-氯-3-[(5-二氢-3-甲基-5-氧代-1-苯基-1H-吡唑-4-基)偶氮]-2-羟基苯磺酸基][4-[(3,5-二氯-2-羟基苯 铁(2+)乙二酸酯-3-甲氧基苯胺(1:1:2) 钠5-苯基-4,5-二氢吡唑-1-羧酸酯 钠3-[2-(2-壬基-4,5-二氢-1H-咪唑-1-基)乙氧基]丙酸酯 钠3-(2H-苯并三唑-2-基)-5-仲-丁基-4-羟基苯磺酸酯 钠(2R,4aR,6R,7R,7aS)-6-(2-溴-9-氧代-6-苯基-4,9-二氢-3H-咪唑并[1,2-a]嘌呤-3-基)-7-羟基四氢-4H-呋喃并[3,2-D][1,3,2]二氧杂环己膦烷e-2-硫醇2-氧化物 野麦枯 野燕枯 醋甲唑胺